Skip to main content

Table 4 Utility of treatments

From: Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial

Period (month)

PCI (n = 194)

Mean ± SD

Imputation, n (%)

MT (n = 197)

Mean ± SD

Imputation, n (%)

CABG (n = 188)

Mean ± SD

Imputation n, (%)

Baseline

0.77 ± 0.84 [0.76]

0 (0)

0.76 ± 0.72 [0.76]

0 (0)

0.75 ± 0.07 [0.72]

0 (0)

6

0.79 ± 0.16 [0.79]

5 (2.6)

0.78 ± 0.11 [0.78]

3 (1.5)

0.78 ± 0.13 [0.77]

4 (2.2)

12

0.78 ± 0.19 [0.81]

4 (2.2)

0.77 ± 0.15 [0.78]

5 (2.6)

0.78 ± 0.16 [0.77]

6 (3.3)

24

0.76 ± 0.21 [0.80]

4 (2.2)

0.73 ± 0.22 [0.76]

9 (4.9)

0.76 ± 0.18 [0.78]

12 (6.7)

36

0.77 ± 0.21 [0.81]

5 (2.7)

0.69 ± 0.27 [0.76]

11 (6.3)

0.76 ± 0.21 [0.80]

14 (8.6)

48

0.75 ± 0.24 [0.81]

12 (6.7)

0.66 ± 0.30 [0.76]

10 (6.1)

0.74 ± 0.24 [0.79]

13 (7.9)

60

0.72 ± 0.29 [0.81]

8 (4.7)

0.65 ± 0.31 [0.75]

8 (4.9)

0.72 ± 0.28 [0.78]

11 (6.6)

  1. Values in brackets represent medians; 5000 replications
  2. MT medical treatment, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CI confidence interval, SD standard deviation